Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin’s lymphoma: results from the randomized international GHSG HD18 trial
-
Published:2023-12
Issue:
Volume:
Page:
-
ISSN:0923-7534
-
Container-title:Annals of Oncology
-
language:en
-
Short-container-title:Annals of Oncology
Author:
Ferdinandus J.ORCID, Müller H., Damaschin C., Jacob A.S., Meissner J., Krasniqi F., Mey U., Schöndube D., Thiemer J., Mathas S., Zijlstra J., Greil R., Feuring-Buske M., Markova J.ORCID, Rüffer J.U., Kobe C., Eich H.-T., Baues C., Fuchs M., Borchmann P., Behringer K.
Subject
Oncology,Hematology
Reference23 articles.
1. Hodgkin’s disease survivors more fatigued than the general population;Loge;J Clin Oncol,1999 2. Cancer-related fatigue in patients with and survivors of Hodgkin’s lymphoma: a longitudinal study of the German Hodgkin Study Group;Kreissl;Lancet Oncol,2016 3. Cancer-related fatigue in patients with and survivors of Hodgkin lymphoma: the impact on treatment outcome and social reintegration;Behringer;J Clin Oncol,2016 4. PET-guided treatment in patients with advanced-stage Hodgkin’s lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group;Borchmann;Lancet,2017 5. PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial;Kreissl;Lancet Haematol,2021
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|